Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 47


Novel report of expression and function of CD97 in malignant gliomas: correlation with Wilms tumor 1 expression and glioma cell invasiveness.

Chidambaram A, Fillmore HL, Van Meter TE, Dumur CI, Broaddus WC.

J Neurosurg. 2012 Apr;116(4):843-53. doi: 10.3171/2011.11.JNS111455. Epub 2012 Feb 7.


LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.

Ward Y, Lake R, Yin JJ, Heger CD, Raffeld M, Goldsmith PK, Merino M, Kelly K.

Cancer Res. 2011 Dec 1;71(23):7301-11. doi: 10.1158/0008-5472.CAN-11-2381. Epub 2011 Oct 6.


Glioblastoma angiogenesis and tumor cell invasiveness are differentially regulated by β8 integrin.

Tchaicha JH, Reyes SB, Shin J, Hossain MG, Lang FF, McCarty JH.

Cancer Res. 2011 Oct 15;71(20):6371-81. doi: 10.1158/0008-5472.CAN-11-0991. Epub 2011 Aug 22.


Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.

Gilbert MR, Kuhn J, Lamborn KR, Lieberman F, Wen PY, Mehta M, Cloughesy T, Lassman AB, Deangelis LM, Chang S, Prados M.

J Neurooncol. 2012 Jan;106(1):147-53. doi: 10.1007/s11060-011-0650-1. Epub 2011 Jul 8.


Epidermal growth factor module-containing mucin-like receptor 2 is a newly identified adhesion G protein-coupled receptor associated with poor overall survival and an invasive phenotype in glioblastoma.

Rutkowski MJ, Sughrue ME, Kane AJ, Kim JM, Bloch O, Parsa AT.

J Neurooncol. 2011 Nov;105(2):165-71. doi: 10.1007/s11060-011-0576-7. Epub 2011 Apr 19.


Epidermal growth factor induces matrix metalloproteinase-1 (MMP-1) expression and invasion in glioma cell lines via the MAPK pathway.

Anand M, Van Meter TE, Fillmore HL.

J Neurooncol. 2011 Sep;104(3):679-87. doi: 10.1007/s11060-011-0549-x. Epub 2011 Feb 27.


EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target.

Kane AJ, Sughrue ME, Rutkowski MJ, Phillips JJ, Parsa AT.

Neuroreport. 2010 Nov 17;21(16):1018-22. doi: 10.1097/WNR.0b013e32833f19f2.


Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance.

Lin ME, Herr DR, Chun J.

Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):130-8. doi: 10.1016/j.prostaglandins.2009.02.002. Epub 2009 Mar 4. Review.


alpha5beta1 integrin antagonists reduce chemotherapy-induced premature senescence and facilitate apoptosis in human glioblastoma cells.

Martinkova E, Maglott A, Leger DY, Bonnet D, Stiborova M, Takeda K, Martin S, Dontenwill M.

Int J Cancer. 2010 Sep 1;127(5):1240-8. doi: 10.1002/ijc.25187.


Overexpression of CD97 in intestinal epithelial cells of transgenic mice attenuates colitis by strengthening adherens junctions.

Becker S, Wandel E, Wobus M, Schneider R, Amasheh S, Sittig D, Kerner C, Naumann R, Hamann J, Aust G.

PLoS One. 2010 Jan 13;5(1):e8507. doi: 10.1371/journal.pone.0008507.


Adhesion-GPCRs: emerging roles for novel receptors.

Yona S, Lin HH, Siu WO, Gordon S, Stacey M.

Trends Biochem Sci. 2008 Oct;33(10):491-500. doi: 10.1016/j.tibs.2008.07.005. Epub 2008 Sep 11. Review.


Individual cell-based models of tumor-environment interactions: Multiple effects of CD97 on tumor invasion.

Galle J, Sittig D, Hanisch I, Wobus M, Wandel E, Loeffler M, Aust G.

Am J Pathol. 2006 Nov;169(5):1802-11.


CD97 neutralisation increases resistance to collagen-induced arthritis in mice.

Kop EN, Adriaansen J, Smeets TJ, Vervoordeldonk MJ, van Lier RA, Hamann J, Tak PP.

Arthritis Res Ther. 2006;8(5):R155.


Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.

Levin VA, Phuphanich S, Yung WK, Forsyth PA, Maestro RD, Perry JR, Fuller GN, Baillet M.

J Neurooncol. 2006 Jul;78(3):295-302. Epub 2006 Apr 25.


Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults.

Parsa AT, Wachhorst S, Lamborn KR, Prados MD, McDermott MW, Berger MS, Chang SM.

J Neurosurg. 2005 Apr;102(4):622-8.


Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines.

Park JW, Zarnegar R, Kanauchi H, Wong MG, Hyun WC, Ginzinger DG, Lobo M, Cotter P, Duh QY, Clark OH.

Thyroid. 2005 Mar;15(3):222-31.


Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group.

N Engl J Med. 2005 Mar 10;352(10):987-96.


Expression of the epidermal growth factor seven-transmembrane member CD97 correlates with grading and staging in human oral squamous cell carcinomas.

Mustafa T, Eckert A, Klonisch T, Kehlen A, Maurer P, Klintschar M, Erhuma M, Zschoyan R, Gimm O, Dralle H, Schubert J, Hoang-Vu C.

Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):108-19.


CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells.

Wang T, Ward Y, Tian L, Lake R, Guedez L, Stetler-Stevenson WG, Kelly K.

Blood. 2005 Apr 1;105(7):2836-44. Epub 2004 Dec 2.


Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma cell line via RNA interference reduces tumor cell invasion, tumor growth and angiogenesis.

Lakka SS, Gondi CS, Yanamandra N, Olivero WC, Dinh DH, Gujrati M, Rao JS.

Oncogene. 2004 Jun 10;23(27):4681-9.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk